Terms: = Uterine cancer AND PR, PGR, progesterone receptor AND Diagnosis
297 results:
1. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
2. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract] [Full Text] [Related]
3. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
5. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
Šavrova A; Jaal J; Nõmm O; Innos K
Public Health; 2023 Dec; 225():369-375. PubMed ID: 37989009
[TBL] [Abstract] [Full Text] [Related]
6. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
[TBL] [Abstract] [Full Text] [Related]
7. Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States.
Dinicu AI; Dioun S; Goldberg M; Crookes DM; Wang Y; Tergas AI
Cancer Med; 2023 Dec; 12(23):21452-21464. PubMed ID: 37964735
[TBL] [Abstract] [Full Text] [Related]
8. [diagnosis and treatment of intravenous leiomyomatosis].
Wen YL; Ma GT; Miao Q
Zhonghua Wai Ke Za Zhi; 2023 Dec; 61(12):1051-1057. PubMed ID: 37932140
[TBL] [Abstract] [Full Text] [Related]
9. ZC3H7B-BCOR Fusion High-grade Endometrial Stromal Sarcoma With Morphologic Features of Low-grade Endometrial Stromal Sarcoma. A Case Report and Review of Literature.
Zhao L; Cheng YW; Policarpio-Nicolas MLC
Int J Gynecol Pathol; 2023 Nov; 42(6):597-601. PubMed ID: 37562066
[TBL] [Abstract] [Full Text] [Related]
10. Assessing Geographic Variation in Rates of Cervical cancer and Recurrent or Metastatic Cervical cancer Among Medicaid Enrollees.
Leath CA; Nysenbaum J; Ting J; Zhang YJ; Fiori A; Pauly N
Am J Clin Oncol; 2023 Sep; 46(9):392-398. PubMed ID: 37459055
[TBL] [Abstract] [Full Text] [Related]
11. A Case of uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
Ise K; Tanei ZI; Oda Y; Tanikawa S; Sugino H; Ishida Y; Tsuda M; Gotoda Y; Nishiwaki K; Yanai H; Hasegawa T; Nagashima K; Tanaka S
Int J Gynecol Pathol; 2024 Jan; 43(1):41-46. PubMed ID: 37406360
[TBL] [Abstract] [Full Text] [Related]
12. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
13. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
14. uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract] [Full Text] [Related]
15. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
16. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
17. Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study.
Bjørge T; Hjellvik V; Bjørge L; Dos-Santos-Silva I; Furu K; Kvåle R; Engeland A
BJOG; 2023 Jun; 130(7):770-778. PubMed ID: 36700296
[TBL] [Abstract] [Full Text] [Related]
18. Primary HPV-Associated Enteric-Type Adenocarcinoma of Vagina: A Case Report.
Felicelli C; Strickland A; Wei JJ
Int J Surg Pathol; 2023 Oct; 31(7):1393-1397. PubMed ID: 36694422
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial cancer.
Huang Y; Jiang P; Kong W; Tu Y; Li N; Wang J; Zhou Q; Yuan R
J Invest Surg; 2023 Dec; 36(1):2152508. PubMed ID: 36521837
[TBL] [Abstract] [Full Text] [Related]
20. The statuses of HER2 expression and mismatch repair in endometrial clear cell carcinoma.
Bayramoglu Z; Erozbek SY; Ozdemir IA; Ulker V; Muezzinoglu B
Pathol Res Pract; 2023 Jan; 241():154258. PubMed ID: 36516643
[TBL] [Abstract] [Full Text] [Related]
[Next]
